MYOPEPDYS (vesleteplirsen) injection Logo (EUIPO, 01/24/2024)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark MYOPEPDYS (vesleteplirsen) injection was filed as Figurative mark on 01/24/2024 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/16/2024.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Punctuation marks, brackets, quotation marks #Two polygons, one inside the other (except 26.5.10 and 26.5.11)
| Trademark form | Figurative mark |
| File reference | 018977600 |
| Application date | January 24, 2024 |
| Publication date | February 7, 2024 |
| Entry date | May 16, 2024 |
| Expiration date | January 24, 2034 |
Trademark owner
215 First Street
02142 Cambridge
US
02142 Cambridge
US
Trademark representatives
Ferdinand-Happ-Str. 32
60314 Frankfurt
DE
goods and services
5
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases
41
Medical training and teaching
44
Medical services; providing health information
ID: 11018977600